Immunosuppressive Inosine Monophosphate Dehydrogenase Inhib.

The class "Immunosuppressive Inosine Monophosphate Dehydrogenase Inhib." (or immunosuppressive inosine monophosphate dehydrogenase inhibitors) is a standard formulary classification for antiproliferative immunosuppressant agents, principally represented by mycophenolate mofetil and mycophenolic acid

The class "Immunosuppressive Inosine Monophosphate Dehydrogenase Inhib." (or immunosuppressive inosine monophosphate dehydrogenase inhibitors) is a standard formulary classification for antiproliferative immunosuppressant agents, principally represented by mycophenolate mofetil and mycophenolic acid Clinically, these agents are primarily indicated for the prophylaxis of organ rejection in solid organ transplantation—such as kidney, heart, and liver allografts—and are widely utilized to manage se...

These medications function by reversibly and noncompetitively inhibiting inosine monophosphate dehydrogenase, the rate-limiting enzyme in de novo guanine nucleotide synthesis

These medications function by reversibly and noncompetitively inhibiting inosine monophosphate dehydrogenase, the rate-limiting enzyme in de novo guanine nucleotide synthesis Clinically, these agents are primarily indicated for the prophylaxis of organ rejection in solid organ transplantation—such as kidney, heart, and liver allografts—and are widely utilized to manage severe autoimmune conditions, including lupus nephritis

Because lymphocytes rely almost entirely on this de novo pathway rather than the purine salvage pathway, the resulting depletion of guanosine nucleotides selectively suppresses T- and B-cell proliferation and immune responses

Because lymphocytes rely almost entirely on this de novo pathway rather than the purine salvage pathway, the resulting depletion of guanosine nucleotides selectively suppresses T- and B-cell proliferation and immune responses

Clinically, these agents are primarily indicated for the prophylaxis of organ rejection in solid organ transplantation—such as kidney, heart, and liver allografts—and are widely utilized to manage severe autoimmune conditions, including lupus nephritis